These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

629 related articles for article (PubMed ID: 19296986)

  • 1. Evaluating use patterns of and adherence to medications for benign prostatic hyperplasia.
    Nichol MB; Knight TK; Wu J; Barron R; Penson DF
    J Urol; 2009 May; 181(5):2214-21; discussion 2221-2. PubMed ID: 19296986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study.
    Kok ET; Schouten BW; Bohnen AM; Groeneveld FP; Thomas S; Bosch JL
    J Urol; 2009 Feb; 181(2):710-6. PubMed ID: 19091352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in alpha blocker usage among enlarged prostate patients receiving combination therapy with 5 ARIs.
    Naslund M; Black L; Eaddy M; Batiste LR
    Am J Manag Care; 2007 Feb; 13 Suppl 1():S17-22. PubMed ID: 17295601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of medication nonadherence among patients with diabetes in Medicare Part D programs: a retrospective cohort study.
    Yang Y; Thumula V; Pace PF; Banahan BF; Wilkin NE; Lobb WB
    Clin Ther; 2009 Oct; 31(10):2178-88; discussion 2150-1. PubMed ID: 19922889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Factors influencing finasteride medication compliance in outpatients with benign prostatic hyperplasia].
    Lin YH; Wang JS; Jiang YG; Luo Y
    Zhonghua Nan Ke Xue; 2012 Oct; 18(10):891-5. PubMed ID: 23297496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Finasteride versus dutasteride: a real-world economic evaluation.
    Fenter TC; Runken MC; Black L; Eaddy M
    Am J Manag Care; 2007 Feb; 13 Suppl 1():S23-8. PubMed ID: 17295602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binge drinking, poor mental health, and adherence to treatment among California adults with asthma.
    Haskard KB; Banta JE; Williams SL; Haviland MG; DiMatteo MR; Przekop P; Werner LS; Anderson DL
    J Asthma; 2008 Jun; 45(5):369-76. PubMed ID: 18569229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of adherence among Alzheimer's disease patients receiving oral therapy.
    Borah B; Sacco P; Zarotsky V
    Curr Med Res Opin; 2010 Aug; 26(8):1957-65. PubMed ID: 20569067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in initial benign prostatic hyperplasia management between primary care physicians and urologists.
    Hollingsworth JM; Hollenbeck BK; Daignault S; Kim SP; Wei JT
    J Urol; 2009 Nov; 182(5):2410-4. PubMed ID: 19765742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors related to antipsychotic oversupply among Central Texas Veterans.
    Yang M; Barner JC; Worchel J
    Clin Ther; 2007 Jun; 29(6):1214-25. PubMed ID: 17692735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of fixed-dose and multi-pill combination dyslipidemia therapies on medication adherence and the economic burden of sub-optimal adherence.
    Balu S; Simko RJ; Quimbo RM; Cziraky MJ
    Curr Med Res Opin; 2009 Nov; 25(11):2765-75. PubMed ID: 19785511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical predictors in the use of finasteride for control of gross hematuria due to benign prostatic hyperplasia.
    Kearney MC; Bingham J; Bergland R; Meade-D'Alisera P; Puchner PJ
    J Urol; 2002 Jun; 167(6):2489-91. PubMed ID: 11992064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: experience in a multistate Medicaid population, 1998-2003.
    Morrato EH; Dodd S; Oderda G; Haxby DG; Allen R; Valuck RJ
    Clin Ther; 2007 Jan; 29(1):183-95. PubMed ID: 17379060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of secondary preventive medications after the first attack of acute coronary syndrome.
    Salomaa V; Pääkkönen R; Hämäläinen H; Niemi M; Klaukka T
    Eur J Cardiovasc Prev Rehabil; 2007 Jun; 14(3):386-91. PubMed ID: 17568237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A large retrospective analysis of acute urinary retention and prostate-related surgery in BPH patients treated with 5-alpha reductase inhibitors: dutasteride versus finasteride.
    Issa MM; Runken MC; Grogg AL; Shah MB
    Am J Manag Care; 2007 Feb; 13 Suppl 1():S10-6. PubMed ID: 17295600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and biological characteristics of familial benign prostatic hyperplasia.
    Sanda MG; Doehring CB; Binkowitz B; Beaty TH; Partin AW; Hale E; Stoner E; Walsh PC
    J Urol; 1997 Mar; 157(3):876-9. PubMed ID: 9072590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective claims database analysis to determine relationship between renin-angiotensin system agents, rehospitalization, and health care costs in patients with heart failure or myocardial infarction.
    Sun SX; Ye X; Lee KY; Dupclay L; Plauschinat C
    Clin Ther; 2008; 30 Pt 2():2217-27. PubMed ID: 19281916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Finasteride in benign prostatic hyperplasia.
    Verhamme KM; Bosch RJ; Sturkenboom MC
    N Engl J Med; 2004 Mar; 350(13):1359-61; author reply 1359-61. PubMed ID: 15049034
    [No Abstract]   [Full Text] [Related]  

  • 19. Antihypertensive medication adherence in the Department of Veterans Affairs.
    Siegel D; Lopez J; Meier J
    Am J Med; 2007 Jan; 120(1):26-32. PubMed ID: 17208076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Waxing and waning gynecomastia: an indication of noncompliant use of prescribed medication.
    Miller JA; Pramanik B; Gilhooly P
    South Med J; 1999 Jun; 92(6):615-7. PubMed ID: 10372857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.